EFDID: 480803EFD: View Filing

Issuer: GENEOS Therapeutics, Inc. (0001769177) - D

Accession: 0001769177-23-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001769177
  • Entity Name:
    GENEOS Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    660 WEST GERMANTOWN PIKE
    SUITE LL110
    PLYMOUTH MEETING, PA 19462
  • Persons:
    Related Persons 7
    Niranjan Y. Sardesai
    Executive Officer, Director
    James Eadie
    Director
    Laurent Humeau
    Director
    Casey Cunningham
    Director
    Samuel Broder
    Director
    Sangwoo Lee
    Director
    Ted Fjallman
    Director
EDGAR: Offering Information
  • Accession Date:
    04/12/2023
  • First Sale Date:
    03/31/2023
  • Offering Amount:
    $9,999,996
  • Amount Sold:
    $4,999,998
  • Amount Remaining:
    $4,999,998
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
GENEOS Therapeutics, Inc./S/ Niranjan Y. SardesaiNiranjan Y. SardesaiChief Executive Officer2023-04-12